Straits Research Reveals Insights into the Global Viral Vector Manufacturing Market

New York, NY, December 23, 2024 — Straits Research, a leading global market research firm, has released a comprehensive report on the viral vector manufacturing market. The market, valued at USD 355 million in 2022, is projected to reach USD 1,790 million by 2031, growing at a robust CAGR of 19.7% during the forecast period (2023–2031). This significant growth is attributed to the increasing demand for viral vectors in gene therapy, vaccine development, and the rising investments in biotechnology research.

Market Definition:

Viral vector manufacturing refers to the production of viral vectors, which are essential tools for gene therapy and vaccine development. These vectors, including retroviruses, adenoviruses, and lentiviruses, are used to deliver genetic material into cells to treat diseases or generate vaccines. The process involves multiple stages, from vector amplification and editing to purification and fill-finish. With advancements in gene therapy, the demand for high-quality viral vectors has surged, fueling the market's growth.

For a full PDF sample copy of the report, visit: Viral Vector Manufacturing Market Sample

Market Dynamics:

Key Trends:

1. Rising Adoption of Gene Therapy: Gene therapy is one of the key areas where viral vectors are extensively used. The increasing prevalence of genetic disorders, cancer, and other chronic diseases has led to significant advancements in gene therapies, fueling the demand for viral vectors in treatment development.

2. Growth in Vaccine Development: With the global focus on developing vaccines, especially in the wake of the COVID-19 pandemic, viral vectors have become a vital part of vaccine production. Companies are increasingly investing in viral vector-based vaccine platforms, driving the market's expansion.

3. Technological Advancements in Viral Vector Production: Innovations in viral vector production technologies, such as improvements in vector amplification and harvesting techniques, are contributing to the market's growth. These advancements are enabling more efficient, cost-effective, and scalable production processes.

Market Drivers:

1. Rising Demand for Gene and Cell Therapies: The increasing success of gene therapies in treating rare genetic diseases and certain cancers has led to a surge in demand for viral vectors. The growing approval of gene therapies and cell-based treatments is expected to drive the viral vector manufacturing market significantly.

2. Increased Investments in Biotechnology and Healthcare Research: Governments and private organizations are increasing their investments in biotechnology and healthcare research. These investments are accelerating the development of gene therapies and personalized medicines, which, in turn, are propelling the demand for viral vectors in various therapeutic applications.

Market Opportunities:

1. Expanding Applications in Cancer Treatment: Viral vectors are playing an increasingly important role in developing targeted cancer therapies, including oncolytic virotherapy. The rising demand for personalized and advanced cancer therapies presents a significant growth opportunity for the viral vector manufacturing market.

2. Growth in Emerging Markets: The increasing adoption of advanced biotechnological solutions in emerging markets, particularly in Asia-Pacific, presents significant growth opportunities. As these regions continue to improve healthcare infrastructure and research capabilities, the demand for viral vectors is expected to rise, creating new market opportunities.

Market Segmentation:

The viral vector manufacturing market is segmented based on type, workflow, application, disease, and end-user. Below are the detailed categories:

• By Type:

  1. Viral Vectors
     • Retroviruses
     • Adenoviruses
     • Adeno-associated viruses (AAVs)
     • Lentiviruses
     • Others
  2. Plasmid DNA

• By Workflow:

  1. Upstream Manufacturing
     • Vector Amplification, Editing, and Expansion
     • Vector Recovery/Harvesting
  2. Downstream Manufacturing
     • Purification
     • Fill Finish

• By Application:

  1. Cell and Gene Therapy
  2. Vaccine Development
  3. Research

• By Disease:

  1. Cancer
  2. Genetic Disorders
  3. Infectious Diseases

• By Application:

  1. Gene Therapy
  2. Vaccinology

• By End-User:

  1. Pharmaceutical and Biopharmaceutical Companies
  2. Academics and Research Institutes
  3. Others

For detailed market segmentation, visit: Viral Vector Manufacturing Market Segmentation

Key Players in the Viral Vector Manufacturing Market:

1. Merck GA
2. Lonza
3. BD
4. Fujifilm Diosynth Biotechnologies USA Inc.
5. Brammer Bio
6. Cell Therapy Catapult Limited
7. Waisman Biomanufacturing
8. GENEZEN LABORATORIES
9. Yposkesi Inc.
10. REGENXBIO Inc.

Geographical Insights:

• Dominated Region: North America is the leading region in the viral vector manufacturing market, primarily due to the presence of established pharmaceutical companies, robust healthcare infrastructure, and high demand for gene therapies. The U.S. is a key contributor to this market, with significant investments in biotechnology research and healthcare innovation.

• Fastest Growing Region: Asia-Pacific is the fastest-growing region in the viral vector manufacturing market. Countries such as China and India are witnessing rapid advancements in biotechnology research, growing healthcare infrastructure, and increasing investments in pharmaceutical and biotechnology companies, fueling the demand for viral vector-based therapies.

Conclusion:

The global viral vector manufacturing market is on a strong growth trajectory, driven by increasing demand for gene therapies, vaccine development, and advances in biotechnology. As the market continues to evolve, new applications in cancer treatment, genetic disorders, and infectious diseases will present significant opportunities for industry players. North America will continue to dominate the market, while the Asia-Pacific region shows promising growth potential.

For more information, queries, or to customize your purchase before buying, visit: Viral Vector Manufacturing Market Purchase

About Straits Research:

Straits Research is a globally recognized market research and consulting firm, providing actionable insights and strategic market reports to help organizations navigate complex industries. With an in-depth understanding of market dynamics, Straits Research offers clients high-quality, data-driven analysis to help them make informed business decisions and drive growth.

For press inquiries, please contact:

Straits Research
Email: info@straitsresearch.com
Phone: +1-800-123-4567
Website: www.straitsresearch.com

This press release outlines key insights into the viral vector manufacturing market, highlighting market trends, drivers, opportunities, and regional dynamics to support stakeholders in making well-informed decisions in this rapidly growing sector.